Investing in China’s Healthcare Sector – New Issue of China Briefing Magazine
- Understanding China’s Rapidly Growing Healthcare Market
- Tapping into China’s Healthcare Boom: Trends and Opportunities
- Key Considerations for Entering China’s Healthcare Market
China is a highly promising market for the global healthcare industry, boasting immense size, diversity, and growth potential.
In 2021, the healthcare market generated RMB 10 trillion (approx. US$1.5 trillion) in total revenue, making it the world’s second-largest.
This figure is expected to continue to grow in the coming decades, propelled by a combination of government support and China’s changing demographics.
Facing a rapidly aging population and the surge in demand for superior healthcare and service, the government has made healthcare sector development a top priority.
Numerous opportunities will arise for players in different parts of the supply chain, including drug R&D, equipment production, caregiving, and niche areas such as biotech, digital healthcare, MedTech, and AI healthcare.
That said, China’s healthcare market is also heavily regulated, with strict compliance requirements and intense competition. To succeed in this booming sector, foreign investors must grasp the evolving needs of Chinese consumers and the pertinent industry policies and regulatory developments.
In this issue of China Briefing Magazine, we explore the opportunities and challenges present in China’s healthcare sector. We begin by providing an overview of the healthcare market and outlining growth factors. Next, we investigate leading healthcare trends and delve into niche sectors. Finally, we highlight key considerations for entering China’s healthcare market and summarize critical success factors.
We hope this magazine can help your business prepare to thrive in this rapidly expanding market.
To know more about the implications of China’s green and low-carbon transition on your businesses or new investment opportunities in associated industries in China, please feel free to contact our experts at firstname.lastname@example.org.
China Briefing is written and produced by Dezan Shira & Associates. The practice assists foreign investors into China and has done so since 1992 through offices in Beijing, Tianjin, Dalian, Qingdao, Shanghai, Hangzhou, Ningbo, Suzhou, Guangzhou, Dongguan, Zhongshan, Shenzhen, and Hong Kong. Please contact the firm for assistance in China at email@example.com.
Dezan Shira & Associates has offices in Vietnam, Indonesia, Singapore, United States, Germany, Italy, India, and Russia, in addition to our trade research facilities along the Belt & Road Initiative. We also have partner firms assisting foreign investors in The Philippines, Malaysia, Thailand, Bangladesh.
- Previous Article What Are the Tax Incentives in China to Encourage Technology Innovation? (updated)
- Next Article China Extends Raft of Preferential Tax Policies and Fee Cuts